




Fat Shot Drug
37K posts

@Biotech_FC
Chelsea. Celtics. Terps. stocks, macro, politics










【兴证电子】英飞凌开启第二轮调价,AI需求旺盛,建议关注功率板块 #更新:英飞凌5月26号发布第二轮涨价函,上轮调价是二月发布涨价函,4.1落地,本轮5.26发布涨价函,7.1落地,两轮涨价表示功率行业需求旺盛,行业上行周期已至。

$BPMC bought by roche Ayvakit market pro-forma Q1 sales of $207M, a 38% increase YoY; relevant for $COGT

Example: CPO testing or HBM - bottleneck huge future demand - power semis & MLCCs Supply crunch - raw materials for CCL



几个值得重点关注的“实质性垄断”标的: - MSSCORP (6830):在检测和 CPO 良率把控上构筑了极深的专利护城河。 - $SOI:主导绝缘体上硅 (SOI) 衬底市场。 - NGK (5333):稳拿薄膜铌酸锂 (TFLN) 晶圆核心技术。 - $AXTI:把控磷化铟 (InP) 衬底等上游关键材料。 像讯芯 (Shunsin) 这类公司其实很难被轻易颠覆,毕竟背靠富士康,而富士康本身就深深扎根于众多核心供应链的腹地 🏭 $SIVE 的逻辑也极其相似。他们已经成功打入 (design in) 了众多顶尖 CPO 架构的设计体系,抱紧了 Ayar、Lightelligence (壁仞的供应商)、Lightmatter 以及 Celestial 等 众行业领军者的大腿 相比之下,个人认为 $HIMX (奇景光电) 或 Foci (上诠) 未来面临被踢出局 (design out) 的风险最大,很有可能会被台积电的光学部门采钰 (Visera 6789) 这类巨头直接垂直整合。不过话说回来,在未来两三年内,借助 CPO 相关的光纤阵列 (FAU) 和无源器件,他们眼前依然有 波巨大的赚钱机遇


RFK Jr: Children who are circumcised early have double the rate of autism Trump: I've studied this a long time

Rumblings on the street is that Vance got caught leaking something Trump didn't like, something only Vance could have known.



A lot of people confuse bottleneck, supply crunch and huge future demand with one another